Brinker Capital’s Genomic Health, Inc. GHDX Stock Holding History

Brinker Capital’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6,810	Closed	-$462K	–	998
2019 Q3	$462K	Buy	6,810 +929	+16%	+$63.8K	0.02%	721
2019 Q2	$342K	Sell	5,881 -828	-12%	-$49.1K	0.01%	780
2019 Q1	$470K	Buy	+6,709	New	+$497K	0.02%	693

Brinker Capital's GHDX Position: Q4 2019 in Review

Brinker Capital sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 6,810 shares — an estimated $462K sold.

Brinker Capital first reported a position in GHDX in Q1 2019 and held it in 3 quarters. The position peaked at $470K in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Brinker Capital reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Brinker Capital sold 6,810 Genomic Health, Inc. shares in Q4 2019, an estimated $462K.
Brinker Capital first reported a position in Genomic Health, Inc. in Q1 2019 and held it in 3 quarters.
Brinker Capital's Genomic Health, Inc. position peaked at $470K in Q1 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Brinker Capital's 13F filing for Q4 2019, filed 18 Feb 2020.